← Open Payments lookup

GABBRIELLE KNABE: Open Payments

NPI 1891233896 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$364 in 20 payments from 8 companies in 2025. Trend: 2023 $258 · 2024 $187 · 2025 $364

Food & beverage: $364
CompanyPaymentsAmount
Abbott Laboratories6$107
ABBVIE INC.4$86
Dexcom, Inc.3$54
Novo Nordisk Inc3$45
Astellas Pharma US Inc1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Exact Sciences Corporation1$17
Aimmune Therapeutics, Inc.1$14

Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, VRAYLAR, Ozempic, Veozah, PROCLAIM, MAVYRET, CAPLYTA.

Industry payments across AZ — which companies pay providers there.